Myovant Sciences Ltd

Market cap: $2,620,491,766

Exchange: NYS

Sector: Health Technology

Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of women's health and endocrine diseases. The company's product includes relugolix, which is an oral, once-daily and small molecule that acts as a GnRH receptor antagonist. It also develops MVT-602 a kisspeptin agonist for the treatment of female infertility. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.

STOCK PRICE CHART

Key Statistics

Company Name

Myovant Sciences Ltd

Average Volume (10 days)

1,572,759

Average Volume (30 days)

1,097,921

Moving Average (50 days)

$26.91

Moving Average (200 days)

$24.59

Ex-Divided Date

n/a

Dividend Yield

P/E Ratio

Market Cap

2,620,491,766

Shares Outstanding

97,235,316

52-Week High Split Adjust Only

27.06

52-Week Low Split Adjust Only

7.67

Employee Count

579

Beta

Next Earnings Date

TTM Dividend Rate Per Share

Price Changes

Past 5 days

Past 30 days

Past 3 months

Past 6 months

0.55%

Past year

1.23%

Past 2 years

0.28%

Past 5 years

0.8%

Max % Change

1.03%

PEER GROUP COMPARATIVE PERFORMANCE

Name	Ticker	Price/Sales (ttm)	Price/Book (ttm)	Forward P/E	PEG Ratio	EV/Revenue
Myovant Sciences Ltd	MYOV	n/a	n/a	n/a	n/a	n/a
Peer Avg	N/A	n/a	n/a	-0.7	n/a	n/a
Ovid Therapeutics Inc	OVID	n/a	n/a	2.0	n/a	n/a
Oyster Point Pharma Inc	OYST	n/a	n/a	-4.9	n/a	n/a